Haris Jawaid

ORCID: 0000-0003-1879-4139 · 1 paper in corpus

review 2021

Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis

·doi:10.1186/s43043-021-00064-5

Abstract Background Heavy menstrual bleeding (HMB) is a common clinical finding in patients with uterine leiomyomas that can negatively impact their quality of life. Recently, a novel oral GnRH-antagonist (elagolix) has emerged as a possibl…